April 25, 2012
/PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in
the People's Republic of China
, today announced that effective
April 20, 2012
, the Company's Board of Directors (the "Board") appointed Mr.
Sandy (Han) Zhang
as two new independent directors of the Company. The Board recently adopted a series of measures to improve the Company's corporate governance, especially to enhance the independence and transparency of the Board.
Chao Ming (Colin) Zhao
, China Biologic's President & Chief Executive Officer, said, "We welcome Mr. Tong and Ms. Zhang to our Board of Directors and believe that their valuable additions will contribute to the success of China Biologic. We expect that Ms. Zhang's acute financial knowledge and Mr. Tong's diversified broad experience in the pharmaceutical industries, plus his in-depth understanding of the U.S. and Chinese business environment, will give us valuable operational oversight and further enhance our corporate governance program. The two appointments prove that we are taking action based on our new corporate governance policy."
has served as the chairman of the board of directors of several companies, including Spain Qifa Corporation Ltd., since 1996; Hong Kong Tong's Group, since 2007; Sunstone (
) Plant Oil Co., Ltd., since 2008; Sunstone (
) Food Co., Ltd., since 2009; Shengda (Zhangjiakou) Pharmaceutical Co., Ltd., since 2011; and Shengda (Qianxi) Chinese Medicine Cultivation Co., Ltd., since 2012. He has also served as a director and a vice president of Spain International Haisitan Group since 1993. From 2007 to 2011, Mr. Tong served as the president and director of BMP Sunstone Corporation, a NASDAQ-listed pharmaceutical corporation. He is 52 years old.
Sandy (Han) Zhang
has served as a consultant at Resources Global Professionals Consulting,
, since 2006. Ms. Zhang also has worked as an associate at Deloitte & Touche Corporate Finance Pte Ltd.,
; as a senior auditor at Deloitte & Touche LLP,
; and as a financial manager at Hypac, a division of Terex Corporation, from
. She is 39 years old.
About China Biologic Products, Inc.